CRNX
Price
$32.13
Change
+$0.03 (+0.09%)
Updated
Jun 4 closing price
Capitalization
3.01B
64 days until earnings call
PEPG
Price
$1.50
Change
-$0.01 (-0.66%)
Updated
Jun 5, 10:32 AM (EDT)
Capitalization
49.41M
63 days until earnings call
Interact to see
Advertisement

CRNX vs PEPG

Header iconCRNX vs PEPG Comparison
Open Charts CRNX vs PEPGBanner chart's image
Crinetics Pharmaceuticals
Price$32.13
Change+$0.03 (+0.09%)
Volume$547.25K
Capitalization3.01B
PepGen
Price$1.50
Change-$0.01 (-0.66%)
Volume$200
Capitalization49.41M
CRNX vs PEPG Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. PEPG commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a StrongBuy and PEPG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (CRNX: $32.13 vs. PEPG: $1.51)
Brand notoriety: CRNX and PEPG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 54% vs. PEPG: 43%
Market capitalization -- CRNX: $3.01B vs. PEPG: $49.41M
CRNX [@Biotechnology] is valued at $3.01B. PEPG’s [@Biotechnology] market capitalization is $49.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whilePEPG’s FA Score has 1 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • PEPG’s FA Score: 1 green, 4 red.
According to our system of comparison, PEPG is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 4 TA indicator(s) are bullish while PEPG’s TA Score has 5 bullish TA indicator(s).

  • CRNX’s TA Score: 4 bullish, 4 bearish.
  • PEPG’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PEPG is a better buy in the short-term than CRNX.

Price Growth

CRNX (@Biotechnology) experienced а +7.42% price change this week, while PEPG (@Biotechnology) price change was +2.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.05%. For the same industry, the average monthly price growth was +10.91%, and the average quarterly price growth was -1.52%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

PEPG is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+5.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.01B) has a higher market cap than PEPG($49.4M). CRNX YTD gains are higher at: -37.160 vs. PEPG (-60.158). PEPG has higher annual earnings (EBITDA): -102.93M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. PEPG (97.8M). PEPG has less debt than CRNX: PEPG (18.3M) vs CRNX (50.8M). CRNX has higher revenues than PEPG: CRNX (760K) vs PEPG (0).
CRNXPEPGCRNX / PEPG
Capitalization3.01B49.4M6,093%
EBITDA-373.49M-102.93M363%
Gain YTD-37.160-60.15862%
P/E RatioN/AN/A-
Revenue760K0-
Total Cash1.27B97.8M1,303%
Total Debt50.8M18.3M278%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
66
SMR RATING
1..100
51
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXPEPG
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 8 days ago
87%
Declines
ODDS (%)
Bearish Trend 10 days ago
79%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
69%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THVRX29.680.30
+1.02%
Thornburg International Equity R4
IFAFX26.160.01
+0.04%
American Funds Income Fund of Amer F1
HFAEX15.20N/A
N/A
Hartford Schroders Intl Cntrrn Val C
LICPX16.95N/A
N/A
Lord Abbett International Equity P
RNTTX47.71N/A
N/A
Russell Inv International Devd Mkts M

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+0.78%
XNCR - CRNX
58%
Loosely correlated
-0.44%
IDYA - CRNX
56%
Loosely correlated
-2.50%
DYN - CRNX
56%
Loosely correlated
+1.06%
TRDA - CRNX
55%
Loosely correlated
-3.76%
RVMD - CRNX
55%
Loosely correlated
-0.49%
More

PEPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PEPG has been loosely correlated with SLDB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PEPG jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEPG
1D Price
Change %
PEPG100%
+4.86%
SLDB - PEPG
37%
Loosely correlated
+9.71%
MGNX - PEPG
36%
Loosely correlated
-0.66%
FENC - PEPG
31%
Poorly correlated
-2.54%
IMTX - PEPG
31%
Poorly correlated
-2.21%
XNCR - PEPG
30%
Poorly correlated
-0.44%
More